Halozyme Therapeutics (HALO) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026)

Halozyme Therapeutics (HALO) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Halozyme Therapeutics 9.65 Bn 9.33 Bn 297.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 0.11%
Dec 31, 2025 15.01%
Sep 30, 2025 -0.14%
Jun 30, 2025 -1.78%
Mar 31, 2025 -2.96%
Dec 31, 2024 0.73%
Sep 30, 2024 -0.68%
Jun 30, 2024 -3.93%
Mar 31, 2024 4.17%
Dec 31, 2023 0.37%
Sep 30, 2023 0.15%
Jun 30, 2023 -4.37%
Mar 31, 2023 3.17%
Dec 31, 2022 106.06%
Sep 30, 2022 -1.12%
Jun 30, 2022 335.70%
Mar 31, 2022 -3.20%
Dec 31, 2021 -8.28%
Sep 30, 2021 -5.37%
Jun 30, 2021 -2.26%